e-learning
resources
VALUE-Dx courses
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The science behind rapid diagnostics development for CA-LRTI
T. Bachmann (Edinburgh, United Kingdom)
Source:
Value-Dx event 2019: VALUE-Dx kick off meeting and course
Number:
2
Disease area:
-
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Bachmann (Edinburgh, United Kingdom). The science behind rapid diagnostics development for CA-LRTI. Value-Dx event 2019: VALUE-Dx kick off meeting and course
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Targeted immunomodulation in airway epithelium to treat pneumonia
Clinical case discussion: How clinical trials inform antibiotic stewardship
Occupational COVID-19
Related content which might interest you:
Opportunities of bacteriological diagnostics of a tuberculosis of a lung in a modern stage
Source: Annual Congress 2008 - Diagnosis of tuberculosis: problems and perspectives
Year: 2008
Facts and perspectives in the development of new diagnostics
Source: Annual Congress 2008 - New insights into tuberculosis control
Year: 2008
Diagnosing asthma in the era of personalised medicine: biology, physiology and imaging
Source: Virtual Congress 2021 – Precision medicine in asthma and COPD
Year: 2021
Innovative tools for diagnosis and prevention of paediatric tuberculosis
Source: International Congress 2019 – Recent developments and future perspectives in the diagnosis and treatment of tuberculosis
Year: 2019
Sputum induction for assessment of biomarkers in early development of new drugs for respiratory disease in a proof of concept setting
Source: International Congress 2016 – Airway biomarkers
Year: 2016
Basic science and diagnosis
Source: School Course 2013 - Cystic Fibrosis
Year: 2013
The new horizons of molecular diagnosis: do we still need conventional microbiology?
Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination
Year: 2012
Contemporary diagnostics and staging
Source: Annual Congress 2012 - PG10 An update on mesothelioma diagnostics and treatment
Year: 2012
Tuberculosis prevention must integrate technological and basic care innovation
Source: Eur Respir J 2016; 48: 1531-1532
Year: 2016
From traditional bacteriology to rapid molecular methods: the revolution is going on
Source: Annual Congress 2012 - PG7 TB and MDR-/XDR-TB: what is new in diagnosis, treatment and follow-up (TB PAN-NET)
Year: 2012
Biomarkers and rapid diagnostics in antibiotic stewardship
Source: International Congress 2015 – PG14 Antibiotic stewardship for respiratory infections
Year: 2015
Latest insights and challenges in tuberculosis vaccine development
Source: International Congress 2019 – Tuberculosis: latest advances and challenges in patient management
Year: 2019
COVID-19 vaccines: immunology, regulation and clinical management
Source: Eur Respir Monogr 2021; 94: 244-260
Year: 2021
Characterisation of clinical phenotypes is mandatory for the development of new drugs
Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD
Year: 2014
Perspectives of therapeutic innovation from current progress in the pathobiology of pulmonary hypertension
Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept